BASF and Promega have developed a skin-sensitization test that can be performed in vitro instead of on animals. The test can also help "predict a possible allergic potential more reliably than before," said Robert Landsiedel, head of BASF's short-term toxicology unit. BASF seeks to add a skin barrier to the test, allowing it to assess absorption levels.

Related Summaries